Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 1

2(25.0%)

Phase 4

2(25.0%)

Phase 2

1(12.5%)

8Total

N/A(3)

Phase 1(2)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04019106Phase 1Unknown

Budesonide With Intratracheal Surfactants in Extremely Preterm Infants

Role: collaborator

NCT01834144Not ApplicableTerminated

The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial

Role: collaborator

NCT02162147Completed

How Safe Are Our Pediatric Emergency Departments?

Role: collaborator

NCT01820377Not ApplicableCompleted

The Aboriginal Youth Mentorship Program

Role: collaborator

NCT01911182Phase 2Terminated

Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea

Role: collaborator

NCT01597154Not ApplicableCompleted

Lifestyle Therapy for Youth With Type 2 Diabetes

Role: collaborator

NCT01997762Phase 4Unknown

Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?

Role: collaborator

NCT00755547Phase 4Completed

A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight Youth

Role: collaborator

NCT00141986Phase 1Completed

Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes

Role: collaborator

All 9 trials loaded